Cormorant Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.1M | Sell |
|
|||||
|
2025
Q1 | $69.1M | Buy |
|
|||||
|
2024
Q4 | $43.9M | Sell |
|
|||||
|
2024
Q3 | $47.3M | Hold |
|
|||||
|
2024
Q2 | $47.1M | Sell |
|
|||||
|
2024
Q1 | $99M | Sell |
|
|||||
|
2023
Q4 | $135M | Sell |
|
|||||
|
2023
Q3 | $123M | Buy |
|
|||||
|
2023
Q2 | $71.7M | Sell |
|
|||||
|
2023
Q1 | $75.6M | Buy |
|
|||||
|
2022
Q4 | $10.4M | Sell |
|
|||||
|
2022
Q3 | $14.6M | Hold |
|
|||||
|
2022
Q2 | $13.3M | Sell |
|
|||||
|
2022
Q1 | $15.9M | Sell |
|
|||||
|
2021
Q4 | $27.8M | Sell |
|
|||||
|
2021
Q3 | $82.9M | Sell |
|
|||||
|
2021
Q2 | $115M | Sell |
|
|||||
|
2021
Q1 | $134M | Sell |
|
|||||
|
2020
Q4 | $161M | Hold |
|
|||||
|
2020
Q3 | $85M | Sell |
|
|||||
|
2020
Q2 | $84.5M | Sell |
|
|||||
|
2020
Q1 | $85.5M | Buy |
|
|||||
|
2019
Q4 | $88.1M | Sell |
|
|||||
|
2019
Q3 | $56.2M | Sell |
|
|||||
|
2019
Q2 | $75M | Buy |
|